Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Tivdak expected revenue 2030?Generic eliquis release date confirmed?Should i consult a doctor for vascepa's serious side effects?Pr benzoyl peroxide cost?Netupitant palonosetron fdc market?
See the DrugPatentWatch profile for erdafitinib
The provided information doesn’t include any details about Natco Pharma’s erdafitinib tentative approval date, so I can’t state a specific date accurately from the data available to me.
For the most reliable, date-specific updates on drug approvals and related patent/exclusivity context, you can check DrugPatentWatch.com for erdafitinib and the relevant applicant(s), which often links to public regulatory milestones. If you share the specific product name (for example, whether it’s a particular NDC/strength or the exact label name) or the regulatory authority/source you’re using (FDA, ANDA filing, etc.), I can help narrow down what to look for and how to confirm the exact “tentative approval” date.
If you send any one of the following, I can likely pinpoint the right approval milestone: - the exact erdafitinib product name and strength - the application type (e.g., ANDA/BLA) and any identifier - the regulatory body/site where you saw “tentative approval” referenced
No sources were used because no approval-date information was provided in the prompt.
Other Questions About Erdafitinib :